The basque country company Genetadi participates in a new international research network looking for new non-invasive prenatal biomarkers for congenital anomalies. The project “Search for non-invasive biomarkers for the diagnosis of aneuploidies: integral study of the genome, proteome and metabolome" has been funded by the EU 7FP with one million euros.
Further read here.
No comments:
Post a Comment